Neuspera fetches $26 mln Series B

San Jose, California-based Neuspera Medical Inc, a neuromodulation company, has secured $26 million in Series B funding. The company’s investors include 6 Dimensions Capital, Action Potential Venture Capital, Windham Venture Partners, Delta Capital, LLC and Purple Arch Ventures.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!